News

The trial will evaluate the safety and immunogenicity of the H5N1 vaccine, combined with IDRI’s Glucopyranosyl Lipid A ("GLA") adjuvant. Each study participant in the trial will receive

The patent will provide protection for LOR-253 composition of matter along with the coverage of Lorus lead antimicrobial small molecule LOR-220, which is used to treat drug resistant

As part of the agreement, Merck will bear the costs involved in evaluating the candidate, which Arrowhead obtained from Alvos Therapeutics in April 2012. Arrowhead president and CEO

The patent was awarded based on FDA-authorised clinical study, which showed that the non-toxic dietary supplement (PHC) contributed to healthy outcome for men with recurrent prostate cancer. The

The screening service combines CeeTox in vitro toxicity screening and CDI’s iCell Cardiomyocytes to provide a profile of drug-induced cardiac toxicity early in the drug development cycle. CeeTox

Under the agreement, Zenobia will provide ADDF’s researchers with access to its discovery platform including a gene-to-structure platform with in-house cloning, expression and purification in E coli, insect

Proximagen’s pipeline includes many programs which are in various stages of development across a number of therapeutic classes including CNS, inflammation, oncology and ophthalmology. The acquisition will enable

The orphan drug designation was granted based on a plausible hypothesis for clinical superiority over the approved nitric oxide product. NO is delivered via the company’s GeNOsyl MVG-2000

Viokace, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy. Aptalis president and